Robert McWhirter on BNN.
PLI-T $1.550 Prometic Life Sciences Inc. Prometic Life Sciences Inc. Doing interesting drug trials, with a near-term opportunity for their orphan drug Placminogen, a specialty protein. With Placminogen they can basically sell almost everything they can produce. Earnings estimates for 2019 is basically zero.